Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Depreciation & Amortization (CF) (2021 - 2025)

Historic Depreciation & Amortization (CF) for Core Scientific (CORZ) over the last 5 years, with Q3 2025 value amounting to $16.3 million.

  • Core Scientific's Depreciation & Amortization (CF) fell 4308.67% to $16.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $80.9 million, marking a year-over-year decrease of 3168.96%. This contributed to the annual value of $113.2 million for FY2024, which is 1791.82% up from last year.
  • As of Q3 2025, Core Scientific's Depreciation & Amortization (CF) stood at $16.3 million, which was down 4308.67% from $18.8 million recorded in Q2 2025.
  • Core Scientific's Depreciation & Amortization (CF)'s 5-year high stood at $68.7 million during Q4 2022, with a 5-year trough of $2.9 million in Q1 2021.
  • In the last 5 years, Core Scientific's Depreciation & Amortization (CF) had a median value of $24.2 million in 2023 and averaged $27.5 million.
  • In the last 5 years, Core Scientific's Depreciation & Amortization (CF) soared by 152065.04% in 2022 and then crashed by 6247.02% in 2023.
  • Core Scientific's Depreciation & Amortization (CF) (Quarter) stood at $20.5 million in 2021, then skyrocketed by 235.59% to $68.7 million in 2022, then plummeted by 54.59% to $31.2 million in 2023, then decreased by 16.54% to $26.0 million in 2024, then plummeted by 37.3% to $16.3 million in 2025.
  • Its last three reported values are $16.3 million in Q3 2025, $18.8 million for Q2 2025, and $19.7 million during Q1 2025.